Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male and female healthy volunteers between 18 and 55 years of age.
Body weight less than 110.00 kg inclusive at Screening.
You may not be if
Previous exposure to any anti-IL-12/23 or anti-IL-23 treatment.
Intention to perform strenuous exercise to which the subject is unaccustomed within one week prior to administration of study drug or during the study.
Clareo Health | A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants
